NCT05520034 Reduction of Recurrence of Stroke by Nurse-led Education in Bangladesh
| NCT ID | NCT05520034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hiroshima University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 432 participants |
| Start Date | 2022-10-02 |
| Primary Completion | 2024-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 432 participants in total. It began in 2022-10-02 with a primary completion date of 2024-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke is a major public issue that can be occurred a patient with severe and unbearable disability for a long time. Recurrence of stroke is increasing due to a lack of knowledge and compliance with treatment regarding the modifiable risk factors of stroke and behavioral and lifestyle changes. Nurse-led health education with (self) monitoring of modifiable risk factors and behaviors can be an effective way to create knowledge about the behavioral changes in stroke patients. The investigators hypothesized that health education among first stroke patients and their family caregivers could reduce the stroke recurrence rate by controlling modifiable risk factors compared to the first stroke patients without health education.
Eligibility Criteria
For patient 1. Who was discharged from NINSH to home or who visited NINSH right after getting a stroke 2. First-time stroke 3. All types of strokes, except subarachnoid haemorrhage 4. modified Rankin Scale (0 - 4) 5. Stroke patient who is 18 years old and above 6. Both males \& females 7. Who provided written consent \& willing to participate in the study For family caregivers 1. Primary caregivers irrespective of sex and aged 18 years old and above, living with the patient who take care of an above patient and who meets all of the inclusion criteria (will be decided by one person) 2. Who will provide written consent \& willing to participate in the study Exclusion Criteria: Exclusion criteria of patient 1. Who has stroke with the recurrence 2. Stroke subtype: caused by genetic problems or injury/accident 3. Patients with multi-organ failure or terminal stage 4. Participation in other clinical trials 5. Unwillingness to participate in the study 6. Not having a mobile phone at home 7. mRS 5 Exclusion criteria of caregiver 1. Who is not living with the patient 2. Who is under 18 years old 3. Who is mentally unstable and/or cognitively impaired (diagnosed cases)
Contact & Investigator
KATM Ehsanul Huq, PhD
PRINCIPAL INVESTIGATOR
Hiroshima University
Frequently Asked Questions
Who can join the NCT05520034 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05520034 currently recruiting?
Yes, NCT05520034 is actively recruiting participants. Contact the research team at mahabuba.a32@gmail.com for enrollment information.
Where is the NCT05520034 trial being conducted?
This trial is being conducted at Dhaka, Bangladesh.
Who is sponsoring the NCT05520034 clinical trial?
NCT05520034 is sponsored by Hiroshima University. The principal investigator is KATM Ehsanul Huq, PhD at Hiroshima University. The trial plans to enroll 432 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.